Morgan Stanley Raises China Life (02628) Target Price to HK$25.7, Maintains "Overweight" Rating

Stock News

Sep 22

Morgan Stanley has released a research report updating its financial model for China Life (02628) based on the company's first-half 2025 performance. The report indicates that benefiting from the stock market rally in 2025 and steady sales growth, the firm has revised upward its earnings per share forecasts for China Life from 2025 to 2027 by 13.1%, 1%, and 1.9% respectively. Against the backdrop of margin improvements, new business value growth is expected to reach 6.6%, 8.1%, and 8.5% for each respective year. Adjustments to both embedded value and book value are controlled within 1%. Taking all factors into consideration, Morgan Stanley has raised China Life's target price (base case scenario) from HK$25 to HK$25.7, representing a 2.8% increase, while maintaining an "Overweight" rating.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1198648699"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1198648699\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1198648699?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-22 17:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1198648699","market":"other","top_or_hot":-1,"title":"Morgan Stanley Raises China Life (02628) Target Price to HK$25.7, Maintains \"Overweight\" Rating","media":"Stock News","content":"<p>Morgan Stanley has released a research report updating its financial model for China Life (02628) based on the company's first-half 2025 performance. The report indicates that benefiting from the stock market rally in 2025 and steady sales growth, the firm has revised upward its earnings per share forecasts for China Life from 2025 to 2027 by 13.1%, 1%, and 1.9% respectively. Against the backdrop of margin improvements, new business value growth is expected to reach 6.6%, 8.1%, and 8.5% for each respective year. Adjustments to both embedded value and book value are controlled within 1%. Taking all factors into consideration, Morgan Stanley has raised China Life's target price (base case scenario) from HK$25 to HK$25.7, representing a 2.8% increase, while maintaining an \"Overweight\" rating.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Morgan Stanley Raises China Life (02628) Target Price to HK$25.7, Maintains \"Overweight\" Rating</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMorgan Stanley Raises China Life (02628) Target Price to HK$25.7, Maintains \"Overweight\" Rating\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-09-22 17:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Morgan Stanley has released a research report updating its financial model for China Life (02628) based on the company's first-half 2025 performance. The report indicates that benefiting from the stock market rally in 2025 and steady sales growth, the firm has revised upward its earnings per share forecasts for China Life from 2025 to 2027 by 13.1%, 1%, and 1.9% respectively. Against the backdrop of margin improvements, new business value growth is expected to reach 6.6%, 8.1%, and 8.5% for each respective year. Adjustments to both embedded value and book value are controlled within 1%. Taking all factors into consideration, Morgan Stanley has raised China Life's target price (base case scenario) from HK$25 to HK$25.7, representing a 2.8% increase, while maintaining an \"Overweight\" rating.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SG9999012744.USD","symbol_name":"UNITED ASIAN INCOME (USDHDG) INC","start_time":0,"source_url":"","article_id":"1198648699","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1198648699","pubTimestamp":1758532953,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Morgan Stanley has released a research report updating its financial model for China Life (02628) based on the company's first-half 2025 performance. The report indicates that benefiting from the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"601628":"中国人寿","SG9999012744.USD":"UNITED ASIAN INCOME (USDHDG) INC","02628":"中国人寿","BK1184":"人寿与健康保险","BK1584":"蚂蚁金服概念","LU0287142896.SGD":"Fidelity China Focus A-SGD","SG9999012736.USD":"UNITED ASIAN INCOME (USDHDG) ACC","SG9999012710.SGD":"UNITED ASIAN INCOME (SGDHDG) ACC","LU1046422090.SGD":"Fidelity Pacific A-SGD","BK0196":"行业龙头","BK0207":"保险","LU0307460666.USD":"EASTSPRING INVESTMENTS CHINA EQUITY \"A\" ACC","BK1550":"内险股","LU0588546209.SGD":"Eastspring Investments - China Equity Fund AS SGD","BK1521":"挪威政府全球养老基金持仓","IE0032431581.USD":"PINEBRIDGE GREATER CHINA EQUITY \"A\" (USD) ACC","LU0173614495.USD":"富达中国焦点A","BK0183":"MSCI概念","BK0188":"融资融券","BK0012":"证金概念","SG9999012728.SGD":"United Asian Income Fund Dis SGD","BK0028":"国家队"},"translate_title":"大摩上调国寿(02628)目标价至25.7港元维持“跑赢大盘”评级","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"601628":1,"02628":1},"content_text":"Morgan Stanley has released a research report updating its financial model for China Life (02628) based on the company's first-half 2025 performance. The report indicates that benefiting from the stock market rally in 2025 and steady sales growth, the firm has revised upward its earnings per share forecasts for China Life from 2025 to 2027 by 13.1%, 1%, and 1.9% respectively. Against the backdrop of margin improvements, new business value growth is expected to reach 6.6%, 8.1%, and 8.5% for each respective year. Adjustments to both embedded value and book value are controlled within 1%. Taking all factors into consideration, Morgan Stanley has raised China Life's target price (base case scenario) from HK$25 to HK$25.7, representing a 2.8% increase, while maintaining an \"Overweight\" rating.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}